Seroprevalence and determinants of human herpes virus 8 infection in adult Nigerians with and without HIV-1 infection

African Health Sciences

Volumn 11, Issue 2, 2011, Pages 158-162

  Ogoina, D ^a   Onyemelukwe, G ^a   Musa, B O ^a   Babadoko, A ^a  

^a AHMADU BELLO UNIVERSITY   (Nigeria)

Author keywords

HHV8; HIV 1; KS; Nigeria; Seroprevalence; STD

Indexed keywords

VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; BLOOD TRANSFUSION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIXED INFECTION; NIGERIA; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEVERITY OF ILLNESS INDEX; SEXUALLY TRANSMITTED DISEASES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 79960991207     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Schulz TF. Kaposi's sarcoma associated herpesvirus (Human herpesvirus 8): Epidemiology and Pathogenesis. J of Antimicrobial Chem 2000; 45: 15-27.
2. Ablashi DV, Chatlynne LG, Whitman JE, Cesarman E. Spectrum of Kaposi's sarcoma associated herpesvirus of human herpesvirus 8. Clin Micro Rev 2002, July; 15(13): 439-464.
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DN et al. Identification of herpesvirus like DNA sequences in AIDS associated Kaposi's sarcoma. Science 1994; 266, 1865-1869.
4. Dedicoat M, Newton R. Review of the distribution of Kaposi's sarcoma associated herpesvirus (KSHV) in Africa in relation to incidence of Kaposi' s sarcoma. Br J Cancer 2003; 88: 1-3 PubMed.
5. Eltom MA, Mbulaiteye SN, Dada AJ, Whitby D, Biggar RJ et al. Transmission of Human herpesvirus 8 (HHV8)by sexual activity among adults in Lagos, Nigeria. AIDS 2002, Dec; 16(18): 2473-78.
6. Hladik W, Dollard SC, Downing RG, Kataaha P, Pellett PE, Karon JM et al. Kaposi's sarcoma in Uganda; Risk factors for Human herpevirus 8 (HHV8) infection among blood donors. J Acquir Immune Defic Syndro 2003, Jun; 33(2): 206-10.
7. Engels EA, Atkinson JO, Graubard BJ, McQuillan GN, Gamache C, Mbisa G et al. Risk factors for Human herpesvirus 8 infection among adults in the US and evidence of sexual transmission. J Infect Dis 2007, July; 196 (2): 199-207.
8. Mbulaiteye SM, Pfeiffer RM, Whitby P, Brubaker GR, Shao J, Biggar RJ. Human herpes virus infection within families in rural Tanzania. J Infect Dis 2003 June, 187 (11), 1780-5.
9. Henge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA et al. Update of Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. The Lancet Infect Dis 2002; 2 (5):281-292.
10. Huang L, Chao N, Chen N, Shire H, Change Y, Chuang C et al. Reciprocal regulatory interaction between human herpesvirus 8 and HIV type 1. J Biol Chem 2001; 276(16): 13432 PubMed.
11. Caselli E, Galvan M, Cassai E, Caruso A, Sighinolfi L, Di Luca D. Human herpesvirus 8 (Kaposi's sarcoma associated herpesvirus) ORF 50 interacts synergistically with the Tat gene product in transactivating the HIV-1 long terminal repeats. J of Gen Virol 2001; 82: 1965-70 PubMed.
12. Suchankova A, Stankora N, Roubalova K, Vandava J, Bruchova M. Seroprevalence of HHV8 antibodies among the general population and HIV positive persons in the Czech Republic. J Clin Virol 2003 Sept; 28 (1): 70-76.
13. World health organization (WHO). Revised WHO clinical staging and immunological classification of HIV and case definition of HIV for surveillance 2006. Available at www.who.int
14. Adjei AA, Armah HB, Gbagbo F, Boamali I, Adu-Gyamfi C and Asare I. Seroprevelance of HHV8, CMV and EBV among the general population in Ghana, West Africa. BMC Infectious Dis 2008; 8:111.
15. Ikpatt OF, Ekanem EE, Calabro L, Ogon PM, Chieco-Bianchi L. Seroprevalence of HHV8 among children attending an emergency room in South eastern Nigeria. Nig J Paediatrics 2002; 29(1)
16. Gallo RC. Some aspects of the pathogenesis of HIV-1 associated Kaposi's sarcoma. J Nat Can Instit Mono 1998; 23: 55-57
17. Maglione M, Geotz M, Wang Z, Wagner G, Hilton L, Carter T, Tringale C et al. Antiretroviral (ARV) drug resistance in the developing world: evidence report/technology assessment no 156 (prepared by the southern California evidence based practice centre), Agency for healthcare research and quality. September 2007.